Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 5
Submit an article Journal homepage
154
Views
6
CrossRef citations to date
0
Altmetric
Letter

Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia

Wing-yan AuBlood-med Clinic, Hong KongCorrespondence[email protected]
,
Brian H. LangDepartment of Surgery
,
Bonnie M. W. FongDivision of Clinical Biochemistry, Queen Mary Hospital, Hong Kong
,
Kevin J. MaoDepartment of Surgery
&
Sidney TamDivision of Clinical Biochemistry, Queen Mary Hospital, Hong Kong
Pages 1184-1185 | Received 08 Jul 2013, Accepted 18 Aug 2013, Published online: 23 Sep 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Frank Firkin. (2014) Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?. Leukemia & Lymphoma 55:5, pages 977-978.
Read now

Articles from other publishers (5)

Peter H. Wiernik, Robert E. Gallagher & Martin S. Tallman. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 409 463 .
Harry Iland. 2018. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia 113 132 .
Pallawi Torka, Omar Al Ustwani, Meir Wetzler, Eunice S. Wang & Elizabeth A. Griffiths. (2016) Swallowing a bitter pill–oral arsenic trioxide for acute promyelocytic leukemia. Blood Reviews 30:3, pages 201-211.
Crossref
Harry J Iland, Marnie Collins, Ken Bradstock, Shane G Supple, Alberto Catalano, Mark Hertzberg, Peter Browett, Andrew Grigg, Frank Firkin, Lynda J Campbell, Amanda Hugman, John Reynolds, Juliana Di Iulio, Campbell Tiley, Kerry Taylor, Robin Filshie, Michael Seldon, John Taper, Jeff Szer, John Moore, John Bashford & John F Seymour. (2015) Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. The Lancet Haematology 2:9, pages e357-e366.
Crossref
. (2014) Arsenic trioxide. Reactions Weekly 1532:1, pages 41-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.